Stem Cell Banking Market - Emerging Industry Dynamics

Objectives of this study are:

# To define, describe, and forecast the stem cell banking market by source, service type, application, and region

# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze the market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the market size for North America, Europe, Asia Pacific, and the Rest of the World (RoW)

# To profile key players and comprehensively analyze their global market shares and core competencies

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220680183

Factors Influencing Global Growth:-

Market growth can primarily be attributed to the increase in hematopoietic stem cell transplantation (HSCT) procedures, development of novel technologies for stem cell processing, preservation, and storage, increasing investments in stem cell-based research, and growing awareness on the therapeutic potential of stem cells. 

Restraints:

# High Operational Costs of Stem Cell Banking

# Stringent Regulatory Frameworks

Opportunities:

# Emerging Countries

# Rising Global Burden of Major Diseases

Market Challenge:

# Socio-Ethical Concerns Related to Embryonic Stem Cells

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global stem cell banking market over the forecast period of 2019 to 2027. The market is projected to reach USD 13.86 billion by 2027 from USD 7.26 billion in 2019, at a CAGR of 8.4%.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=220680183

Geographical Growth Scenario:

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share in 2019. The expanding network of stem cell banking services across the region, ongoing approval of stem cell lines for disease treatment (especially for hematopoietic & autoimmune disorders), recent technological advancements in the field of stem cell collection and preservation techniques, and rising public-private investments for stem cell researches are driving the growth of the stem cell banking market in North America.

Leading Market Players:

# Cord Blood Registry (CBR) Systems (US)

# Cordlife Group Limited (Singapore)

# Cryo-Cell International (US)

# ViaCord (US)

# Cryo-Save AG (Netherlands)

# LifeCell International (India) and many more…

These are the several growth strategies such as service launches & upgrades; agreements, partnerships, & collaborations; and mergers & acquisitions were adopted by the market players to strengthen and competitive position in the global stem cell banking market. Among these business strategies, agreements, partnerships, & collaborations were the most widely adopted growth strategies by majority of market players worldwide.

Human Liver Models Market - Emerging Industry Dynamics

Objectives of the Study

# To define, measure, and describe the global human liver model market by type and region

# To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171046468

Factors Influencing Global Growth:-

The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure. 

Restraints:

# Issues Related to the Incorporation of Organoids Into Existing Workflows

Opportunities:

# Increasing Focus on Drug Discovery Activities

# Rising Demand for Liver Transplantation

# Growing Healthcare Market in the Asia Pacific and Latin America

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global human liver models market is expected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6% during the forecast period (2017-2022).

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=171046468

Geographical Growth Scenario:

Geographic segments in this report include North America, Europe, Asia Pacific, and the RoW. Of these, the North American segment accounted for the largest share of the market in 2017. The human liver market for North America is driven by the presence of a well-established life sciences industry, growing awareness about the organoids technology, increasing government funding, growing incidence of NAFLD, and unavailability of livers for transplantation, increasing investments on research, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.

Leading Market Players:

# Emulate (US)

# Ascendance Bio (US)

# HìREL (US)

# CN Bio (UK)

# Organovo (US)

# Cyfuse Biomedical (Japan) and many more…

Veterinary Pain Management Market - Major Growth Boosters

Years considered for this report:

2017 – Base Year

2018 – Estimated Year

2023 – Projected Year

Objectives of the Study

# To define, describe, and forecast the global veterinary pain management market on the basis of product, application, animal type, distribution channel, and region

# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

# To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

# To profile key players and comprehensively analyze their market shares and core competencies in the global market

# To track and analyze competitive developments such as partnerships, agreements, & collaborations; mergers & acquisitions; product developments; and geographical expansions in the global market

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96167677

Factors Influencing Global Growth:-

Market growth can be attributed to growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health. 

Restraints:

# Increasing Pet Care Costs

Opportunities:

# Increasing Popularity of Non-Conventional and Non-Pharmaceutical Treatment Techniques

# Untapped Emerging Markets

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The veterinary pain management market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=96167677

Geographical Growth Scenario:

Global veterinary pain management market has been studied for North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in veterinary pain management market, primarily due to the significant growth in pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China.

Leading Market Players:

# Zoetis (US)

# Merck Animal Health (US)

# Elanco (US)

# Chanelle (Ireland)

# Boehringer Ingelheim (Germany)

# Vetoquinol (France) and many more…

The global veterinary pain management drugs market is a consolidated market, and the top three pharmaceutical companies account for a large share of the global market. Boehringer Ingelheim (Germany), Zoetis (US), Elanco (US), dominated the veterinary pain management drugs market in 2017.

Read the Detailed Research Article, Here@ 

https://www.marketsandmarkets.com/Market-Reports/veterinary-pain-management-market-96167677.html

High Potency APIs Industry - Emerging Trends & Global Future Forecasts

Target Audience for this Report:

# Manufacturers of HPAPI

# Distributors and suppliers of HPAPIs

# Potential investors in the HPAPI market

# Pharmaceutical companies

# Biotechnology companies

# Contract manufacturing organizations

# Life science research centers

# Healthcare payers

Objectives of the Study:

# To define, describe, and forecast the global HPAPI market on the basis of type, type of manufacturer, type of synthesis, therapeutic application, and region

# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

# To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the market segments of North America, Europe, Asia, and the Rest of the World (RoW)

# To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies

# To track and analyze competitive developments such as agreements, partnerships, collaborations, and alliances; mergers and acquisitions; expansions; and R&D activities in the global market

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36582475

Factors Influencing Global Growth:-

The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. 

Restraints:

# Requirement of Large Investments

# Discrepancies in Hpapi Banding Systems

# Uncertainties Associated With Products

# High Risk of Cross-Contamination

Opportunities:

# Growing Opportunities for Cmos and Cdmos

# Emerging Markets

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global HPAPI market is expected to reach USD 26.84 Billion by 2023 from USD 16.49 Billion in 2017, at a CAGR 8.7%. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=36582475

Geographical Growth Scenario:

In 2018, North America is expected to account for the largest share of the market followed by Europe. Factors such growing incidence of cancer, increasing investments in cancer research, technological advancements in HPAPI manufacturing, growing CMOs market, constructive government reforms like the Patient Protection and Affordable Care Act, growing focus of leading pharmaceutical companies in the HPAPIs segment, and increasing demand for antibody-drug conjugates (ADCs) are responsible for the large share of North America in the global HPAPIs market.

Leading Market Players:

# Pfizer (US)

# Novartis International AG (Switzerland)

# Sanofi (France)

# Boehringer Ingelheim (Germany)

# Bristol-Myers Squibb (US)

# Teva (Israel) and many more…

Agreements, partnerships, collaborations, and alliances accounted for the largest share of the overall growth strategies followed by key players between 2015 and 2018.

Read the Detailed Research Article, Here@ 

https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market-36582475.html

Veterinary Pain Management - Secrets Behind the Global Industry Growth

Time Frame Considered for this Study:

# 2017 – Base Year

# 2018 – Estimated Year

# 2023 – Projected Year

Objectives of the Study:

# To define, describe, and forecast the global veterinary pain management market on the basis of product, application, animal type, distribution channel, and region

# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

# To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

# To profile key players and comprehensively analyze their market shares and core competencies in the global market

# To track and analyze competitive developments such as partnerships, agreements, & collaborations; mergers & acquisitions; product developments; and geographical expansions in the global market

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96167677

Target Audience:

# Healthcare institutions (hospitals, medical schools, and outpatient clinics)

# Market research and consulting firms

# Venture capitalists and investors

# Research & development companies

# Veterinary pain management manufacturers and distributors

Factors Influencing Global Growth:-

Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. 

Restraint:

# Increasing Pet Care Costs

Opportunities:

# Increasing Popularity of Non-Conventional and Non-Pharmaceutical Treatment Techniques

# Untapped Emerging Markets

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=96167677

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The veterinary pain management market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period.

Geographical Growth Scenario:

Global veterinary pain management market has been studied for North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in veterinary pain management market, primarily due to the significant growth in pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China.

Leading Market Players:

# Zoetis (US)

# Merck Animal Health (US)

# Elanco (US)

# Chanelle (Ireland)

# Boehringer Ingelheim (Germany)

# Vetoquinol (France) and many more…

To sustain its leading position in the market, the company adopted several growth strategies such as expansions, agreements, and partnerships.

Read the Detailed Research Article, Here@ 

https://www.marketsandmarkets.com/Market-Reports/veterinary-pain-management-market-96167677.html

Sleep Apnea Devices Manufacturing - What Made the Global Industry Grow Rapidly?

The study involved four major activities in estimating the current market size for sleep apnea devices. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and sub-segments

Major Objectives behind This Study:

# To define, describe, and measure the global market by type, end user, and region

# To provide detailed information about major factors influencing market growth (such as drivers, restraints, growth opportunities, and challenges)

# To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the global market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the market in North America, Europe, Asia Pacific (APAC), and the Rest of the world (RoW)

# To strategically analyze the market structure and profile key players and their core competencies3 in the global market

# To track and analyze competitive developments such as service launches, expansions, acquisitions, partnerships & collaborations; in the market.

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

Recent Developments:

# In 2019, ResMed (US) launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the US with a newly designed nasal cradle cushion that sits just under the wearer’s nose.

# In 2016, Koninklijke Philips (Netherlands) launched its Dream Family solution which comprises of a DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app.

Key Questions Addressed by the Report:

# Which type segment will dominate the sleep apnea devices market in the future?

# Emerging countries have immense opportunities for the growth and adoption of sleep apnea devices, therefore will this scenario continue in the next five years? 

# Where will all the advancements in technology offered by various companies take the industry in the mid to long term?

# What are the upcoming alternative therapies and devices related to the same in the sleep apnea devices market?

Factors Influencing Global Growth:-

Growth in the sleep apnea devices market can be attributed to factors such the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding, and the increasing number of companies venturing into sleep apnea and oral appliances markets. 

Restraint:

# High Cost of Cpap Machines

# Complex Referral Pathways and Long Waiting Periods

Opportunities:

# Growing Demand for Home Healthcare

# Increasing Focus on Telemedicine and Mhealth (Mobile Health)

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global sleep apnea devices market is expected to reach USD 7.5 billion by 2024 from USD 4.5 billion in 2019 at a CAGR of 10.7%.

Geographical Growth Scenario:

On the basis of region, North America accounted for the largest share of the global sleep apnea devices market in 2018, whereas, the Asia Pacific region registered the highest CAGR during the forecast period. North American accounted for the largest share owing to factors like an increase in the number of patients diagnosed with sleep apnea in the region, growth in awareness initiatives being taken by various government and non-government organizations, availability of adequate funding for research and development, and substantial growth in the usage of oral appliances in the region.

Leading Market Players:

# ResMed (US)

# Koninklijke Philips (Netherlands)

# Fisher & Paykel Healthcare (New Zealand)

# SomnoMed (US)

# Oventus Medical (Australia)

# Compumedics (Australia) and many more…

Analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as partnerships & agreements, expansions, service launches, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the sleep apnea devices market.

Read the Detailed Research Article, Here@ 

https://www.marketsandmarkets.com/Market-Reports/sleep-apnea-devices-market-719.html

Active Pharmaceutical Ingredient Industry is Expecting Commendable Growth, Worldwide, In Near Future

The study involved four major activities to estimate the current size of the global active pharmaceutical ingredient market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Major Objectives behind This Study:

# To define, describe, and forecast the global APIs market on the basis of type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region

# To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)

# To strategically analyze micro markets with respect to the individual growth trends, future prospects, and contributions to the overall market

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

# To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)

# To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies

# To track and analyze competitive developments such as partnerships, agreements, collaborations, joint ventures, alliances, mergers & acquisitions, approvals, expansions, and R&D activities in the global APIs market.

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263

Recent Developments:

# In January 2018, Pfizer entered into a collaboration with Sangamo Therapeutics, Inc. (US) for the development of a potential gene therapy to treat amyotrophic lateral sclerosis (ALS).

# In May 2018, Novartis acquired AveXis, a clinical-stage gene therapy company, to develop a gene-based treatment for spinal muscular atrophy.

# In January 2018, Sanofi acquired Ablynx, a biopharmaceutical company to strengthen its platform for growth in rare blood disorders.

# In January 2018, Sanofi and Alnylam Pharmaceuticals, Inc. (US) announced a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize the development and commercialization of products prescribed for the treatment of rare genetic diseases.

Key Questions Addressed by the Report:

# Where will all these developments take the industry in the mid to long term?

# What types of annual and multi-year partnerships are API companies exploring?

# Which are the key players in the market and how intense is the competition?

# Which are the recent contracts and agreements key players have signed?

# What are the recent trends affecting the API manufacturers?

Factors Influencing Global Growth:-

The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. 

Restraint:

# Unfavorable Drug Price Control Policies across Various Countries

# Increasing Penetration of Counterfeit Drugs

Opportunities:

# Emerging Biosimilars Market

# Highly Potent Active Pharmaceutical Ingredients

# Emerging Markets

# Emerging Technologies

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=263

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global APIs market is estimated to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period.

Geographical Growth Scenario:

In 2019, North America is expected to dominate the market, followed by Europe. The major factors driving the overall growth of the APIs market in this region include the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. This market segment is expected to grow at a modest rate due to a combination of economic and healthcare severity measures and the introduction of low-cost, generic versions of branded drugs.

Leading Market Players:

# Pfizer, Inc. (US)

# Novartis AG (Switzerland)

# Sanofi (France)

# Boehringer Ingelheim (Germany)

# Bristol-Myers Squibb (US)

# Teva Pharmaceutical Industries Ltd. (Israel) and many more…

These players have adopted various growth strategies, such as partnerships, acquisitions, agreements, and collaborations as well as new product launches, to further expand their presence in the global market.

Acquisitions and collaborations have been the key growth strategies adopted by players from 2016 to 2018.

Read the Detailed Research Article, Here@ 

https://www.marketsandmarkets.com/Market-Reports/API-Market-263.html

Global Healthcare IT Industry - This is What the Future has to Offer

Objectives of this Study:

# To define, describe, and forecast the healthcare IT market based on product & service, component, end user, and region

# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)

# To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market

# To analyze opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders

# To forecast the size of the healthcare IT market with respect to five geographic regions – North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa

# To profile key players in the healthcare IT market and comprehensively analyze their core competencies and market shares

# To track and analyze competitive developments such as agreements, partnerships, and collaborations; mergers and acquisitions; new product/technology/service launches and upgrades; and research and development activities of leading players in the healthcare IT market

Recent Developments:

# In 2019, Philips launched Cares Aging & Caregiving service.

# In 2018, Change Healthcare launched Dx Gap Advisor

# In 2017, Optum acquired DaVita Medical Group (US). The acquisition of DaVita enhanced Optum’s physician-led primary, specialty, in-home, and surgery-care delivery services business.

# In 2017, Cognizant acquired TMG Health (US) to expand its business process-as-a-service solutions for government and public health programs

# In 2018, Optum collaborated with Humana (US), MultiPlan (US)  and Quest Diagnostics (US) to form a group to explore the blockchain technology to improve data quality and reduce administrative costs in healthcare

Get More Details about This Study | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the healthcare IT market?

# What are the driving factors, restraints, opportunities, and challenges in the market?

# What are the industry trends as well as the current scenario in the healthcare IT market?

# What are the growth trends in the market at the segmental and overall market levels?

Expected Revenue Growth in the Global Industry:

The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period.

Factors Responsible for the Global Growth of This Industry:

The growing volume of patient data, an increase in technological know-how, and demand for quick and efficient healthcare processes and systems are driving the demand for HCIT solutions.

Key Market Restraints:

# IT Infrastructural Constraints in Developing Countries

Key Market Opportunities:

# Rising Use of Healthcare IT Solutions in Outpatient Care Facilities

# Growing Mhealth, Telehealth, and Remote Patient Monitoring Markets

# Cloud-Based EHR Solutions

# Shift towards Patient-Centric Healthcare Delivery

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=252

Geographical Growth Scenario:

“North America dominated the Healthcare IT market in 2018”

The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018. 

The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions. Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.

Leading Market Players:

Some of the major players operating in this market include Optum (US), Cerner (US), Cognizant (US), Change Healthcare (US), Philips Healthcare (Netherlands), Epic Systems (US), Dell Technologies (US), Allscripts (US), GE Healthcare (US), IBM (US), Athenahealth (US), Oracle Corporation (US), COnduent (US), Infor (US), Tata Consultancy Services (India), Wipro Limited (India), Conifer Health (US), Nuance (US), 3M (US), Inovalon (US), InterSystems (US), Leidos (US), Softheon (US), Omnicell (US), and Ciox Health (US).

Cerner has a robust healthcare IT product portfolio tailored for medium- and large-sized enterprise customers to help them with advanced software products and services designed specifically for their needs. Its key strength is its wide geographic presence and extensive distribution network across major markets.

Optum provides a variety of healthcare IT solutions such as EHR/EMR solutions, mHealth solutions and services, ePrescribing, healthcare asset management solutions for pharmacies, and revenue cycle management solutions.

Cognizant is a key player in the healthcare IT market for software solutions and services. The company offers cloud-based software-as-a-service (SaaS) and performance improvement solutions to increase administrative efficiency and improve patient quality of care.

Philips is a major player operating in the healthcare IT market. The company offers health information exchange solutions, mHealth solutions, VNAs and PACS, and telehealth solutions that are approved by respective regulatory bodies (such as the US FDA and the CFDA in China) of the major markets in which Philips operates.

Epic Systems offers a wide range of EHR, revenue cycle and practice management, and population health management solutions. The company mainly operates in the North American market. It also has a presence in the Netherlands, the United Arab Emirates, Finland, Australia, Singapore, and Denmark.

Read the Detailed Study on This Topic, Here@ 

https://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Patient Blood Management Techniques - This is What to Expect from the Future

Globally, the demand for donated blood is increasing because of greater volume of sophisticated medical surgical procedures conducted and the increasing number of trauma cases due to road accidents. These procedures require blood transfusions to make up for blood loss incurred during the procedures. Thus, the rising number of accidents, trauma cases, and surgical procedures performed are contributing to the market growth, thereby increasing the need for patient blood management products.

Major Objectives behind This Study:

# To define, describe, and forecast the patient blood management market on the basis of product, component, end user, and region.

# To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges).

# To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To forecast the revenue of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

# To strategically profile the key players and comprehensively analyze their market shares and core competencies.

# To track and analyze competitive developments such as new product launches; agreements, partnerships, and joint ventures; mergers & acquisitions; business expansions and research & development activities in the market.

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131352979

Recent Developments:

# In 2019, Abbott (US) received the US FDA approval for its ‘Alinity s’ blood culture screening system as well as the Afinion HbA1c Dx assay kit.

# In 2019, F. Hoffmann-La Roche LTD (Switzerland) received the US FDA approval for its cobas Babesia Test for donor screening.

# In 2018, Terumo BCT (Japan) and Stafa Cellular Therapy (US) entered into a collaborative agreement. Based on this agreement, Terumo BCT expands access to the StafaCT software to healthcare organizations.

# In 2018, B. Braun Melsungen AG (Ireland) acquired the bloodlines business of NxStage Medical, Inc. (US), which operates under the Medisystems brand.

# In 2018, Abbott (US) received a CE mark for its Alinity h-series to be used in the European Union.

Key Questions Addressed by the Report:

# What are the growth opportunities related to the adoption of patient blood management solutions across the globe in the future?

# Which product segment will register the highest adoption rate during the forecast period?

# Where will the advancements in products offered by various companies take the industry in the mid- to long-term?

# Emerging countries have immense opportunities for the growth of the market. Will this scenario continue in the next five years?

# Which end users are estimated to adopt patient blood management systems?

# What are the key strategies adopted by the key players operating in the market?

Factors Influencing Global Growth:-

The growth of this market is attributed to the increasing demand for donated blood, rising prevalence of target diseases, increasing number of blood donations and blood donors, and technological advancements.

Restraint:

# High Cost Associated With Automated Systems

Opportunity:

# Market Penetration Opportunities in Developing Countries

# Growing Awareness Regarding the Safety of Donated Blood

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=131352979

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global patient blood management market size is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024.

Geographical Growth Scenario:

The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific blood management market is expected to register significant growth over the forecast period due to the modernization of healthcare infrastructure, increasing prevalence of chronic lifestyle diseases, and rising awareness about blood donation & blood safety. China accounted for a major share of the Asia Pacific market, owing to a large patient pool and favorable government guidelines to improve healthcare infrastructure in the country.

Leading Market Players:

# Haemonetics Corporation (US)

# Fresenius SE & Co. KGaA (Germany)

# Terumo Corporation (Japan)

# Immucor, Inc. (US)

# B. Braun Melsungen AG (Ireland)

# Macopharma (US) and many more…

An analysis of market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, collaborations, partnerships, agreements, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the patient blood management market.

Read the Detailed Research Article, Here@ 

https://www.marketsandmarkets.com/Market-Reports/patient-blood-management-market-131352979.html